alnylam pharmaceuticals inc
(ALNY:Consolidated Issue Listed on NASDAQ Global Select )
Mary Beth DeLena
Vice President and Associate General Counsel, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Ms. Mary Beth DeLena serves as Vice President and Associate General Counsel at Alnylam Pharmaceuticals, Inc. Ms. DeLena served as Senior Director of Legal of Alnylam Pharmaceuticals, Inc. She served as a Secretary of Praecis Pharmaceuticals Inc.
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|George W. Hebard III, M.B.A||Interim Principal Executive Officer, Interim Chief Operating Officer and Secretary|
Enzon Pharmaceuticals Inc.
|Peter French B.Sc, M.Sc, Ph.D., MBA||Chief Executive Officer, Managing Director and Director|
Benitec Biopharma Limited
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President and Director|
Galena Biopharma, Inc.
|Mark J. Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|$377.5K||Compensation as of Fiscal Year 2013.|